Follow
Ralph P. Robinson
Ralph P. Robinson
Pfizer Inc
Verified email at thamespharmapartners.com
Title
Cited by
Cited by
Year
Modern advances in heterocyclic chemistry in drug discovery
AP Taylor, RP Robinson, YM Fobian, DC Blakemore, LH Jones, O Fadeyi
Organic & biomolecular chemistry 14 (28), 6611-6637, 2016
6792016
Arylsulfonylamino hydroxamic acid derivatives
RP Robinson, JP Rizzi
US Patent 5,863,949, 1999
2691999
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids
J Jansen, KC Reimer, JS Nagai, FS Varghese, GJ Overheul, M de Beer, ...
Cell Stem Cell 29 (2), 217-231. e8, 2022
1732022
Rational targeting of active-site tyrosine residues using sulfonyl fluoride probes
EC Hett, H Xu, KF Geoghegan, A Gopalsamy, RE Kyne Jr, CA Menard, ...
ACS Chemical Biology 10 (4), 1094-1098, 2015
1652015
Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis.
O FitzGerald, M Soden, G Yanni, R Robinson, B Bresnihan
Annals of the Rheumatic Diseases 50 (11), 792-796, 1991
1521991
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate …
ML Vazquez, N Kaila, JW Strohbach, JD Trzupek, MF Brown, ...
Journal of medicinal chemistry 61 (3), 1130-1152, 2018
1362018
Recent advances in the synthetic chemistry of bicyclo [1.1. 1] pentane
J Kanazawa, M Uchiyama
Synlett 30 (01), 1-11, 2019
1352019
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo [3.2. 1] octane class of sodium-dependent glucose cotransporter 2 inhibitors
V Mascitti, TS Maurer, RP Robinson, J Bian, CM Boustany-Kari, T Brandt, ...
Journal of medicinal chemistry 54 (8), 2952-2960, 2011
1302011
Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole:  Prodrugs for the Enolic OH Group
RP Robinson, LA Reiter, WE Barth, AM Campeta, K Cooper, BJ Cronin, ...
Journal of Medicinal Chemistry 39 (1), 10-18, 1996
1271996
Covalent enzyme inhibition through fluorosulfate modification of a noncatalytic serine residue
OO Fadeyi, LR Hoth, C Choi, X Feng, A Gopalsamy, EC Hett, RE Kyne Jr, ...
ACS Chemical Biology 12 (8), 2015-2020, 2017
1032017
Visible-light-driven photocatalytic initiation of radical thiol–ene reactions using bismuth oxide
OO Fadeyi, JJ Mousseau, Y Feng, C Allais, P Nuhant, MZ Chen, B Pierce, ...
Organic letters 17 (23), 5756-5759, 2015
892015
The glucocorticoid receptor: molecular mechanism and new therapeutic opportunities
L Buckbinder, RP Robinson
Current Drug Targets-Inflammation & Allergy 1 (2), 127-136, 2002
792002
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1
LA Reiter, RP Robinson, KF McClure, CS Jones, MR Reese, PG Mitchell, ...
Bioorganic & medicinal chemistry letters 14 (13), 3389-3395, 2004
762004
Total synthesis of (.+-.)-O-methylorantine
HH Wasserman, RK Brunner, JD Buynak, CG Carter, T Oku, RP Robinson
Journal of the American Chemical Society 107 (2), 519-521, 1985
741985
Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type …
AS Kalgutkar, M Tugnait, T Zhu, E Kimoto, Z Miao, V Mascitti, X Yang, ...
Drug metabolism and disposition 39 (9), 1609-1619, 2011
722011
β-Lactams as building blocks in the synthesis of macrocyclic spermine and spermidine alkaloids
HH Wasserman, H Matsuyama, RP Robinson
Tetrahedron 58 (35), 7177-7190, 2002
722002
Identification of cyanamide-based Janus kinase 3 (JAK3) covalent inhibitors
A Casimiro-Garcia, JI Trujillo, F Vajdos, B Juba, ME Banker, A Aulabaugh, ...
Journal of Medicinal Chemistry 61 (23), 10665-10699, 2018
682018
Aryloxyarylsulfonylamino hydroxamic acid derivatives
RP Robinson
US Patent 6,214,872, 2001
652001
Synthesis of a peptidyl difluoro ketone bearing the aspartic acid side chain: an inhibitor of interleukin-1. beta. converting enzyme
RP Robinson, KM Donahue
The Journal of Organic Chemistry 57 (26), 7309-7314, 1992
641992
Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14
JA Blagg, MC Noe, LA Wolf-Gouveia, LA Reiter, ER Laird, SPP Chang, ...
Bioorganic & medicinal chemistry letters 15 (7), 1807-1810, 2005
632005
The system can't perform the operation now. Try again later.
Articles 1–20